company background image
GSS

Genetic Signatures ASX:GSS Stock Report

Last Price

AU$0.97

Market Cap

AU$139.1m

7D

0%

1Y

-22.4%

Updated

28 Jan, 2023

Data

Company Financials +

GSS Stock Overview

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa.

GSS fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance5/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

Genetic Signatures Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Genetic Signatures
Historical stock prices
Current Share PriceAU$0.97
52 Week HighAU$1.40
52 Week LowAU$0.63
Beta0.19
1 Month Change9.60%
3 Month Change37.59%
1 Year Change-22.40%
3 Year Change-16.38%
5 Year Change193.94%
Change since IPO100.00%

Recent News & Updates

Genetic Signatures Limited (ASX:GSS) Investors Are Less Pessimistic Than Expected

Oct 10
Genetic Signatures Limited (ASX:GSS) Investors Are Less Pessimistic Than Expected

Recent updates

Genetic Signatures Limited (ASX:GSS) Investors Are Less Pessimistic Than Expected

Oct 10
Genetic Signatures Limited (ASX:GSS) Investors Are Less Pessimistic Than Expected

One Genetic Signatures Limited (ASX:GSS) Analyst Just Made A Major Cut To Next Year's Estimates

Jun 29
One Genetic Signatures Limited (ASX:GSS) Analyst Just Made A Major Cut To Next Year's Estimates

Genetic Signatures (ASX:GSS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Feb 28
Genetic Signatures (ASX:GSS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

AU$3.20: That's What Analysts Think Genetic Signatures Limited (ASX:GSS) Is Worth After Its Latest Results

Feb 25
AU$3.20: That's What Analysts Think Genetic Signatures Limited (ASX:GSS) Is Worth After Its Latest Results

What Kind Of Shareholders Hold The Majority In Genetic Signatures Limited's (ASX:GSS) Shares?

Feb 07
What Kind Of Shareholders Hold The Majority In Genetic Signatures Limited's (ASX:GSS) Shares?

What Does Genetic Signatures' (ASX:GSS) CEO Pay Reveal?

Jan 17
What Does Genetic Signatures' (ASX:GSS) CEO Pay Reveal?

Genetic Signatures' (ASX:GSS) Wonderful 522% Share Price Increase Shows How Capitalism Can Build Wealth

Dec 27
Genetic Signatures' (ASX:GSS) Wonderful 522% Share Price Increase Shows How Capitalism Can Build Wealth

Genetic Signatures (ASX:GSS) Is In A Strong Position To Grow Its Business

Dec 06
Genetic Signatures (ASX:GSS) Is In A Strong Position To Grow Its Business

Shareholder Returns

GSSAU Life SciencesAU Market
7D0%0.2%0.6%
1Y-22.4%-48.0%3.5%

Return vs Industry: GSS exceeded the Australian Life Sciences industry which returned -48% over the past year.

Return vs Market: GSS underperformed the Australian Market which returned 3.5% over the past year.

Price Volatility

Is GSS's price volatile compared to industry and market?
GSS volatility
GSS Average Weekly Movement10.3%
Life Sciences Industry Average Movement9.1%
Market Average Movement8.5%
10% most volatile stocks in AU Market15.7%
10% least volatile stocks in AU Market3.5%

Stable Share Price: GSS is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: GSS's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001n/aJohn Melkihttps://www.geneticsignatures.com

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens.

Genetic Signatures Limited Fundamentals Summary

How do Genetic Signatures's earnings and revenue compare to its market cap?
GSS fundamental statistics
Market CapAU$139.11m
Earnings (TTM)AU$3.06m
Revenue (TTM)AU$35.50m

45.4x

P/E Ratio

3.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
GSS income statement (TTM)
RevenueAU$35.50m
Cost of RevenueAU$13.60m
Gross ProfitAU$21.90m
Other ExpensesAU$18.84m
EarningsAU$3.06m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.021
Gross Margin61.69%
Net Profit Margin8.63%
Debt/Equity Ratio0%

How did GSS perform over the long term?

See historical performance and comparison